Isomorphic Labs
SF 8.4DeepMind spinout for AI drug design
DeepMind spinout for AI drug design
AI-powered small molecule design
Quick decision guide
Overview
Isomorphic Labs is a DeepMind spinout building AI models for drug design, including protein structure prediction and molecule generation for pharma partners. The product is positioned around R&D acceleration and computational biology rather than guaranteed clinical outcomes, and engagement typically happens through pharma partnerships rather than self-serve subscription buying. Buyers should weigh data access requirements, expected timelines to validated leads, and the cost structure across collaborations before committing to a long discovery program today.
For large pharma partners and biologics programs, Isomorphic Labs is worth a serious look thanks to frontier ai models for biologics design. The honest trade-off is that not a self-serve buyer product today. Pricing is sales-led and scoped per buyer rather than posted publicly. Buyers should still verify EHR or workflow fit, scope, and support before committing.
Atomwise is an AI-powered drug discovery platform that helps pharmaceutical and biotechnology organisations identify potential small-molecule medicines using deep learning. Built for research teams rather than individual users, it combines virtual screening, structure-based modelling and biological data analysis to support early-stage drug discovery.
• Built for pharmaceutical and biotechnology organisations seeking to accelerate small-molecule drug discovery with AI.
• Uses AtomNet deep learning technology to identify potential drug targets, screen compounds and support structure-based drug design.
• Supports drug discovery across multiple therapeutic areas through research partnerships with pharmaceutical companies.
• Available through partnership agreements rather than self-service, with custom pricing and implementation tailored to each organisation.
Atomwise is best suited to pharmaceutical and biotechnology organisations investing in AI-assisted drug discovery, although its partnership-based model may be less suitable for smaller research teams looking for self-service software.
Side-by-side
OVERLAP
Both tools cover similar catalog signals. The deciding factor is usually workflow fit, implementation needs, and ecosystem fit.
Shared capabilities
Shared workflows
Feature check
The trade-offs
Final verdict
Current catalog data shows meaningful overlap between Isomorphic Labs and Atomwise. Use the signals below to decide based on workflow, ecosystem, pricing, and implementation fit.
Isomorphic Labs and Atomwise share 8 catalog signals, so the decision should focus on fit rather than broad capability alone.
Isomorphic Labs has 4 visible decision signals and Atomwise has 4.
Isomorphic Labs has the higher SoftFinders Score in the current catalog data.